Malaria News and Research

Latest Malaria News and Research

New active compound for the treatment of malaria

Malaria is caused by Plasmodium parasites and it is the female Anopheles mosquito that acts as a vector for these malarial parasites in to the human body.

16 Oct 2007

World Bank updates on malaria situation in Africa

A new World Bank report says in just two years nearly 20 million long lasting insecticidal nets and more than 15 million doses of artemisinin-based combination therapy (ACT) are on course to be distributed under the World Bank Booster Program for Malaria Control in Africa.

12 Oct 2007

Joint effort means 750,000 of the world's poor will have acess to TB drugs

Thanks to a partnership between the World Health Organisation (WHO) and an international initiative, anti-tuberculosis drugs will now be available to people in poor countries.

8 Oct 2007

Malaria remains formidable challenge in the Americas

Malaria remains a formidable challenge for the countries of the Americas and more action is needed to improve national control programs to reduce the burden of the disease, health ministers from the Americas heard today.

8 Oct 2007

Winning the battle against deadly Ebola

The latest reports from the Democratic Republic of the Congo (DRC) say health workers are slowly winning the battle against the deadly Ebola hemorrhagic fever.

2 Oct 2007

Discovery of structure in malaria with potential for a vaccine target

Researchers at the Swedish medical university Karolinska Institutet (KI) and the Swedish Institute for Infectious Disease Control (SMI) have identified the biochemical mechanism behind the adhesive protein that give rise to particularly serious malaria in children.

25 Sep 2007

What gives us sunburn protects crayfish against bacteria

The production of melanin gives us sunburns, but it also helps invertebrate animals to encapsulate attacking fungi and parasites.

25 Sep 2007

International teams fighting deadly Ebola virus in DR Congo

Another four more cases of the Ebola virus have been confirmed in the Democratic Republic of Congo, bringing the total in the country to nine to date.

24 Sep 2007

Insecticide-treated bednet coverage reduces child mortality by 44%

The use of insecticide-treated bednets (ITNs) leads to a 44% reduction in child mortality.

24 Sep 2007

Researchers genetically engineering microorganisms, such as E. coli, into tiny, cellular factories

Microorganisms may soon be efficiently and inexpensively producing novel pharmaceutical compounds, such as flavonoids, that fight aging, cancer or obesity, as well as high-value chemicals, as the result of research being conducted by University at Buffalo researchers.

18 Sep 2007

Nanoparticle that delivers vaccines more effectively

Good news for public health: Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies.

18 Sep 2007

New understanding of the malarial parasite

About 2 million people die of malaria every year, of which more than a million are children in sub-Saharan Africa.

17 Sep 2007

Global child deaths have reached a record low

Global child deaths have reached a record low, falling below 10 million per year to 9.7 million, down from almost 13 million in 1990, according to UNICEF.

13 Sep 2007

Sugar key to malaria parasite invasion

Researchers at the Johns Hopkins Malaria Research Institute (JHMRI) have identified a sugar in mosquitoes that allows the malaria-causing parasite, Plasmodium falciparum, to attach itself to the mosquito's gut.

11 Sep 2007

Experts call for more resources worldwide to deal with mental illness

Experts in Britain are calling for better recognition of the impact of mental illness on other health problems and for more resources worldwide to deal with mental health issues.

5 Sep 2007

Researchers look at malaria resistance to chloroquine

Funded by a $1.5 million grant from the National Institutes of Health (NIH), scientists at Binghamton University, State University of New York, hope to understand how the malaria parasite Plasmodium falciparum evolved resistance to the once-effective medication chloroquine.

3 Sep 2007

Start of Phase II trial of intravenous artesunate for children with severe malaria

A multicentre Phase II trial of intravenous artesunate will begin recruitment of patients in September.

30 Aug 2007

Binghamton University researchers investigate evolving malaria resistance

Funded by a $1.5 million grant from the National Institutes of Health, scientists at Binghamton University, State University of New York, hope to understand how the malaria parasite Plasmodium falciparum evolved resistance to the once-effective medication chloroquine.

30 Aug 2007

New understanding of malaria mosquito's olfactory system

By mapping a specialized sensory organ that the malaria mosquito uses to zero in on its human prey, an international team of researchers has taken an important step toward developing new and improved repellants and attractants that can be used to reduce the threat of malaria, generally considered the most prevalent life-threatening disease in the world.

30 Aug 2007